CT angiography can help clinicians detect cerebral aneurysms smaller than 3 mm.
CT angiography accurately detects small cerebral aneurysms smaller than 3 mm, according to a study published in Radiology.
Researchers from China performed a retrospective study to assess the accuracy of CT angiography for the diagnosis of cerebral aneurysms that were 5 mm or smaller, using digital subtraction angiography (DSA) as a reference standard.
The study group included 1,366 patients who underwent both CT angiography and DSA. Two readers assessed CT performance for depiction of aneurysms, size, location, and status of rupture.
The results showed DSA detected 711 small aneurysms in 579 patients. Using DSA as the reference standard the researchers found:
The researchers noted that the sensitivities of CT angiography were lower for detection of aneurysms smaller than 3 mm and unruptured compared with aneurysms that were 3 to 5 mm and ruptured. There were no differences for the sensitivities of CT angiography for diagnosis of aneurysms in the anterior versus posterior circulation. Excellent or good interreader agreement was found for detection of intracranial aneurysms on a per-patient and per-aneurysm basis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.